• Je něco špatně v tomto záznamu ?

Chrysin, baicalein and galangin are indirect activators of the human constitutive androstane receptor (CAR)

A. Carazo Fernández, T. Smutny, L. Hyrsová, K. Berka, P. Pavek,

. 2015 ; 233 (2) : 68-77.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15022847

The constitutive androstane receptor (CAR) is a crucial transcriptional regulator of key xenobiotic-metabolizing enzymes such as cytochrome P450 CYP3A4, CYP2C9 and CYP2B6. The flavonoids chrysin, baicalein and galangin have been reported to activate CAR and interfere with EGFR signaling. Nevertheless, it is not known if these flavonoids are direct CAR ligands or indirect phenobarbital-like CAR activators via the inhibition of epidermal growth factor receptor (EGFR) signaling. We analyze the interactions of chrysin, galangin and baicalein and its glycoside baicalin with human CAR. We have employed and validated methods that can study direct interaction with the CAR ligand binding pocket. Secondly, we determined if the compounds affect human EGFR signaling and interact with EGFR. Employing a TR-FRET coactivator assay with recombinant CAR or CAR assembly assay, a consistent activation of CAR with flavonoids and phenobarbital was not observed. It was determined, however, that galangin, chrysin, and baicalein may slightly repress EGFR-Tyr1068 autophosphorylation after EGF treatment, phosphorylation of downstream transcription factor ELK1 and stimulate EGFP-CAR nuclear translocation in primary human hepatocytes. These data suggest that flavonoids chrysin, galangin and baicalein are indirect human CAR activators. This study also demonstrates new approach how to test the direct CAR interaction with its ligands.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15022847
003      
CZ-PrNML
005      
20150723103738.0
007      
ta
008      
150709s2015 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.toxlet.2015.01.013 $2 doi
035    __
$a (PubMed)25625231
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Carazo Fernández, Alejandro $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czech Republic.
245    10
$a Chrysin, baicalein and galangin are indirect activators of the human constitutive androstane receptor (CAR) / $c A. Carazo Fernández, T. Smutny, L. Hyrsová, K. Berka, P. Pavek,
520    9_
$a The constitutive androstane receptor (CAR) is a crucial transcriptional regulator of key xenobiotic-metabolizing enzymes such as cytochrome P450 CYP3A4, CYP2C9 and CYP2B6. The flavonoids chrysin, baicalein and galangin have been reported to activate CAR and interfere with EGFR signaling. Nevertheless, it is not known if these flavonoids are direct CAR ligands or indirect phenobarbital-like CAR activators via the inhibition of epidermal growth factor receptor (EGFR) signaling. We analyze the interactions of chrysin, galangin and baicalein and its glycoside baicalin with human CAR. We have employed and validated methods that can study direct interaction with the CAR ligand binding pocket. Secondly, we determined if the compounds affect human EGFR signaling and interact with EGFR. Employing a TR-FRET coactivator assay with recombinant CAR or CAR assembly assay, a consistent activation of CAR with flavonoids and phenobarbital was not observed. It was determined, however, that galangin, chrysin, and baicalein may slightly repress EGFR-Tyr1068 autophosphorylation after EGF treatment, phosphorylation of downstream transcription factor ELK1 and stimulate EGFP-CAR nuclear translocation in primary human hepatocytes. These data suggest that flavonoids chrysin, galangin and baicalein are indirect human CAR activators. This study also demonstrates new approach how to test the direct CAR interaction with its ligands.
650    _2
$a vazebná místa $x účinky léků $7 D001665
650    _2
$a buněčné linie $7 D002460
650    _2
$a cytochrom P450 CYP2B6 $x metabolismus $7 D065702
650    _2
$a flavanony $x farmakologie $7 D044950
650    _2
$a flavonoidy $x farmakologie $7 D005419
650    _2
$a hepatocyty $x účinky léků $x metabolismus $7 D022781
650    _2
$a lidé $7 D006801
650    _2
$a fenobarbital $x farmakologie $7 D010634
650    _2
$a transport proteinů $x účinky léků $7 D021381
650    _2
$a erbB receptory $x účinky léků $7 D066246
650    _2
$a receptory cytoplazmatické a nukleární $x agonisté $7 D018160
650    _2
$a protein Elk-1 s doménou ets $x účinky léků $x genetika $7 D050807
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Smutny, Tomas $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czech Republic.
700    1_
$a Hyrsová, Lucie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czech Republic.
700    1_
$a Berka, Karel $u Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry Palacky University in Olomouc, 17. listopadu 1131, Olomouc CZ779 00, Czech Republic.
700    1_
$a Pavek, Petr $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czech Republic. Electronic address: petr.pavek@faf.cuni.cz.
773    0_
$w MED00004537 $t Toxicology letters $x 1879-3169 $g Roč. 233, č. 2 (2015), s. 68-77
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25625231 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150723103814 $b ABA008
999    __
$a ok $b bmc $g 1083186 $s 905840
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 233 $c 2 $d 68-77 $i 1879-3169 $m Toxicology letters $n Toxicol Lett $x MED00004537
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...